A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families

被引:0
作者
Serova, O
Montagna, M
Torchard, D
Narod, SA
Tonin, P
Sylla, B
Lynch, HT
Feunteun, J
Lenoir, GM
机构
[1] INT AGCY RES CANC,F-69372 LYON,FRANCE
[2] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE
[3] MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA
[4] MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA
[5] CREIGHTON UNIV,SCH MED,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have analyzed 20 breast-ovarian cancer families, the majority of which show positive evidence of linkage to chromosome 17q12, for germ-line mutations in the BRCA1 gene. BRCA1 mutations cosegregating with breast and ovarian cancer susceptibility were identified in 16 families, including 1 family with a case of male breast cancer. Nine of these mutations have not been reported previously. The majority of mutations were found to generate a premature stop codon leading to the formation of a truncated BRCA1 protein of 2%-88% of the expected normal length. Two mutations altered the RING finger domain. Sequencing of genomic DNA led to the identification of a mutation in the coding region of BRCA1 in 12 families, and cDNA analysis revealed an abnormal or missing BRCA1 transcript in 4 of the 8 remaining families. A total of eight mutations were associated with a reduced quantity of BRCA1 transcript. We were unable to detect BRCA1 mutations in 4 of the 20 families, but only 1 of these was clearly linked to BRCA1. Ir is expected that the majority of clear examples of the breast-ovarian cancer syndrome will be associated with germ-line mutations in the coding region of BRCA1.
引用
收藏
页码:42 / 51
页数:10
相关论文
共 50 条
  • [41] Founder BRCA1/2 mutations in the Europe: Implications for hereditary breast-ovarian cancer prevention and control
    Janavičius R.
    [J]. EPMA Journal, 2010, 1 (3) : 397 - 412
  • [42] BRCA1 and BRCA2 Mutations in Women of Different Ethnicities Undergoing Testing for Hereditary Breast-Ovarian Cancer
    Hall, Michael J.
    Reid, Julia E.
    Burbidge, Lynn A.
    Pruss, Dmitry
    Deffenbaugh, Amie M.
    Frye, Cynthia
    Wenstrup, Richard J.
    Ward, Brian E.
    Scholl, Thomas A.
    Noll, Walter W.
    [J]. CANCER, 2009, 115 (10) : 2222 - 2233
  • [43] Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
    van der Kolk, Dorina M.
    de Bock, Geertruida H.
    Leegte, Beike K.
    Schaapveld, Michael
    Mourits, Marian J. E.
    de Vries, Jakob
    van der Hout, Annemieke H.
    Oosterwijk, Jan C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (03) : 643 - 651
  • [44] Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age
    Dorina M. van der Kolk
    Geertruida H. de Bock
    Beike K. Leegte
    Michael Schaapveld
    Marian J. E. Mourits
    Jakob de Vries
    Annemieke H. van der Hout
    Jan C. Oosterwijk
    [J]. Breast Cancer Research and Treatment, 2010, 124 : 643 - 651
  • [45] Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families
    Kim, TJ
    Lee, KM
    Choi, CH
    Lee, JW
    Lee, JH
    Bae, DS
    Kim, BG
    [J]. ONCOLOGY REPORTS, 2006, 15 (03) : 565 - 569
  • [46] COMMON ORIGINS OF BRCA1 MUTATIONS IN CANADIAN BREAST AND OVARIAN-CANCER FAMILIES
    SIMARD, J
    TONIN, P
    DUROCHER, F
    MORGAN, K
    ROMMENS, J
    GINGRAS, S
    SAMSON, C
    LEBLANC, JF
    BELANGER, C
    DION, F
    LIU, Q
    SKOLNICK, M
    GOLDGAR, D
    SHATTUCKEIDENS, D
    LABRIE, F
    NAROD, SA
    [J]. NATURE GENETICS, 1994, 8 (04) : 392 - 398
  • [47] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    Ligtenberg, MJL
    Hogervorst, FBL
    Willems, HW
    Arts, PJW
    Brink, G
    Hageman, S
    Bosgoed, EAJ
    Van der Looij, E
    Rookus, MA
    Devilee, P
    Vos, EMAW
    Wigbout, G
    Struycken, PM
    Menko, FH
    Rutgers, EJT
    Hoefsloot, EH
    Mariman, ECM
    Brunner, HG
    Van't Veer, LJ
    [J]. BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1475 - 1478
  • [48] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    [J]. DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [49] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    M J L Ligtenberg
    F B L Hogervorst
    H W Willems
    P J W Arts
    G Brink
    S Hageman
    E A J Bosgoed
    E Van der Looij
    M A Rookus
    P Devilee
    E M A W Vos
    G Wigbout
    P M Struycken
    F H Menko
    E J Th Rutgers
    E H Hoefsloot
    E C M Mariman
    H G Brunner
    L J Van’t Veer
    [J]. British Journal of Cancer, 1999, 79 : 1475 - 1478
  • [50] Screening for BRCA1 and BRCA2 mutations in eastern Finnish breast/ovarian cancer families
    Hartikainen, J. M.
    Kataja, V.
    Pirskanen, M.
    Arffman, A.
    Ristonmaa, U.
    Vahteristo, P.
    Ryynanen, M.
    Heinonen, S.
    Kosma, V-M
    Mannermaa, A.
    [J]. CLINICAL GENETICS, 2007, 72 (04) : 311 - 320